# CLDND1

## Overview
The CLDND1 gene encodes the protein claudin domain containing 1, which is a critical component of tight junctions in epithelial and endothelial cells. This protein is categorized as a transmembrane protein and plays a pivotal role in maintaining the selective permeability barrier essential for tissue integrity and cellular homeostasis (Matsuoka2017The; Ohnishi2017Claudin). CLDND1 is particularly significant in the human brain, where it is highly expressed in the cerebellum and contributes to the regulation of vascular permeability, thereby preventing pathological conditions such as vascular edema and stroke (Ohnishi2017Claudin; Shima2020Transcription). The expression of CLDND1 is tightly regulated by transcription factors such as MZF1 and RORα, which ensure the proper formation and maintenance of tight junctions (Matsuoka2017The; Shima2020Transcription). Alterations in CLDND1 expression have been linked to various diseases, including cerebrovascular disorders and cancer, highlighting its clinical significance (Ohnishi2017Claudin; Achari2015Down).

## Function
The CLDND1 gene encodes a protein that is integral to the formation and maintenance of tight junctions (TJs) in epithelial and endothelial cells. These tight junctions are crucial for maintaining the selective permeability barrier, which regulates the passage of molecules between cells and maintains tissue integrity (Matsuoka2017The; Ohnishi2017Claudin). In human brain endothelial cells, CLDND1 is strongly expressed in the cerebellum and plays a significant role in maintaining vascular permeability, which is essential for preventing conditions such as vascular edema and stroke (Ohnishi2017Claudin; Shima2020Transcription).

The transcription of CLDND1 is regulated by several factors, including the myeloid zinc finger 1 (MZF1) and the retinoic acid receptor-related orphan receptor α (RORα). MZF1 binds to a silencer region in the CLDND1 promoter, enhancing its transcription and thereby contributing to the formation of tight junctions (Shima2020Transcription). RORα also positively regulates CLDND1 expression by binding to a specific response element in its promoter, which is crucial for maintaining the integrity of tight junctions in brain endothelial cells (Matsuoka2017The). These regulatory mechanisms highlight the importance of CLDND1 in maintaining cellular barriers and vascular integrity.

## Clinical Significance
Alterations in the expression of the CLDND1 gene, also known as claudin domain containing 1, have been implicated in various diseases, particularly those involving vascular permeability and cancer. In the context of cerebrovascular diseases, downregulation of CLDND1 is associated with increased vascular permeability, which is a risk factor for conditions such as cerebral hemorrhage. This downregulation can lead to increased permeability in brain endothelial cells, contributing to edema and potentially exacerbating neurodegenerative processes following hemorrhagic events (Ohnishi2017Claudin; Shima2020Transcription).

In cancer, particularly breast cancer, CLDND1 plays a role in cell survival. Downregulation of CLDND1 induces apoptosis in certain breast cancer cell lines, such as MDA-MB-231 and MDA-MB-468, suggesting that CLDND1 is crucial for the survival of these cells. This indicates that CLDND1 may be involved in the mechanisms of malignancy and resistance to cell death in cancer (Achari2015Down).

The regulation of CLDND1 expression is also influenced by signaling pathways, such as the EGF-dependent activation of ELK1, which can be targeted by drugs like gefitinib to potentially regulate CLDND1 expression in cancer therapy (Matsuoka2022EGFDependent).

## Interactions



## References


[1. (Matsuoka2022EGFDependent) Hiroshi Matsuoka, Alice Yamaoka, Takahiro Hamashima, Akiho Shima, Marin Kosako, Yuma Tahara, Jun Kamishikiryo, and Akihiro Michihara. Egf-dependent activation of elk1 contributes to the induction of cldnd1 expression involved in tight junction formation. Biomedicines, 10(8):1792, July 2022. URL: http://dx.doi.org/10.3390/biomedicines10081792, doi:10.3390/biomedicines10081792. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biomedicines10081792)

[2. (Shima2020Transcription) Akiho Shima, Hiroshi Matsuoka, Alice Yamaoka, and Akihiro Michihara. Transcription of cldnd1 in human brain endothelial cells is regulated by the myeloid zinc finger 1. Clinical and Experimental Pharmacology and Physiology, 48(2):260–269, October 2020. URL: http://dx.doi.org/10.1111/1440-1681.13416, doi:10.1111/1440-1681.13416. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/1440-1681.13416)

[3. (Matsuoka2017The) Hiroshi Matsuoka, Akiho Shima, Arisa Uda, Hirotaka Ezaki, and Akihiro Michihara. The retinoic acid receptor-related orphan receptor α positively regulates tight junction protein claudin domain-containing 1 mrna expression in human brain endothelial cells. Journal of Biochemistry, pages mvw092, January 2017. URL: http://dx.doi.org/10.1093/jb/mvw092, doi:10.1093/jb/mvw092. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/jb/mvw092)

[4. (Ohnishi2017Claudin) Masatoshi Ohnishi, Hiroyuki Ochiai, Kohei Matsuoka, Marina Akagi, Yuta Nakayama, Akiho Shima, Arisa Uda, Hiroshi Matsuoka, Jun Kamishikiryo, Akihiro Michihara, and Atsuko Inoue. Claudin domain containing 1 contributing to endothelial cell adhesion decreases in presence of cerebellar hemorrhage. Journal of Neuroscience Research, 95(10):2051–2058, February 2017. URL: http://dx.doi.org/10.1002/jnr.24040, doi:10.1002/jnr.24040. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jnr.24040)

[5. (Achari2015Down) Chandrani Achari, Sofia Winslow, and Christer Larsson. Down regulation of cldnd1 induces apoptosis in breast cancer cells. PLOS ONE, 10(6):e0130300, June 2015. URL: http://dx.doi.org/10.1371/journal.pone.0130300, doi:10.1371/journal.pone.0130300. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0130300)